Stock INDOCO INDOCO REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Indoco Remedies Limited

Equities

INDOCO

INE873D01024

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:48 2024-05-03 am EDT 		5-day change 1st Jan Change
337.7 INR +1.90% Intraday chart for Indoco Remedies Limited +2.77% -14.55%
Mar. 29 Indoco Remedies Limited Announces Cessation of Divakar M. Gavaskar and Rajiv P. Kakodkar as Independent Directors, Effective Mach 31, 2024 CI
Mar. 26 Indoco Remedies Arm Begins Commercial Production from New Manufacturing Unit MT

Business Summary

Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company offers medicines in multiple therapeutic categories, such as diabetology, respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care medicine. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel among others. The Company caters to both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited.

Number of employees: 6,000

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
94.6 %
14,160 91.9 % 15,779 94.6 % +11.44%
Services
3.7 %
878 5.7 % 622 3.7 % -29.18%
Exchange Gain/(Loss) (Net) (Other than Considered in Finance Cost)
1.2 %
332 2.2 % 205 1.2 % -38.16%
Export Incentives
0.4 %
32 0.2 % 74 0.4 % +134.24%
Scrap
0.0 %
7 0.0 % 6 0.0 % -2.94%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
15,408 100.0 % 16,686 100.0 % +8.30%

Managers

Managers TitleAgeSince
Aditi Kare Panandikar CEO
 Chief Executive Officer 54 04-03-26
Pramod Ghorpade DFI
 Director of Finance/CFO - 21-09-01
Suresh Govind Kare CHM
 Chairman 85 63-07-01
Ramanathan Hariharan CMP
 Compliance Officer - 14-12-31
Kavita lnamdar CTO
 Chief Tech/Sci/R&D Officer 57 10-06-07
Sundeep Vasant Bambolkar BRD
 Director/Board Member 63 81-12-31

Members of the board

Members of the board TitleAgeSince
Suresh Govind Kare CHM
 Chairman 85 63-07-01
Sundeep Vasant Bambolkar BRD
 Director/Board Member 63 81-12-31
Aditi Kare Panandikar CEO
 Chief Executive Officer 54 04-03-26
Anand Madhusudan Nadkarni BRD
 Director/Board Member 65 14-05-27
Vasudha Vasant Kamat BRD
 Director/Board Member 71 20-03-26
Abhijit Yashwant Gore BRD
 Director/Board Member 59 20-10-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 92,182,205 31,547,407 ( 34.22 %) 0 34.22 %

Shareholders

NameEquities%Valuation
SPA Holdings Pvt Ltd.
19.90 %
18,335,000 19.90 % 72 M ₹
Shanteri Investment Pvt Ltd.
17.12 %
15,771,755 17.12 % 62 M ₹
Aditi Milind Panandikar
6.068 %
5,592,000 6.068 % 22 M ₹
Ramani Madhura Anup
5.642 %
5,199,000 5.642 % 20 M ₹
Kare Aruna Suresh
5.203 %
4,794,714 5.203 % 19 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
4.970 %
4,579,483 4.970 % 18 M ₹
quant Money Managers Ltd.
4.557 %
4,198,980 4.557 % 17 M ₹
Suresh Govind Kare
4.406 %
4,060,408 4.406 % 16 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
2.830 %
2,607,842 2.830 % 10 M ₹
DSP Asset Managers Pvt. Ltd.
1.837 %
1,692,679 1.837 % 7 M ₹

Company contact information

Indoco Remedies Ltd.

Indoco House, Santacruz East 166 CST Road

400098, Mumbai

+91 22 6287 1000

http://www.indoco.com
address Indoco Remedies Limited(INDOCO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Indoco Remedies Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
337.7 INR
Average target price
395.2 INR
Spread / Average Target
+17.03%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
INDOCO REMEDIES LIMITED Stock Indoco Remedies Limited
-14.55% 373M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INDOCO Stock
  4. Company Indoco Remedies Limited